Société de Therapeutique Marocaine S.A. (CBSE:SOT)
Morocco flag Morocco · Delayed Price · Currency is MAD
298.00
-9.50 (-3.09%)
At close: Oct 30, 2026

CBSE:SOT Income Statement

Millions MAD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
3,4723,2262,8162,4862,3022,056
3,4723,2262,8162,4862,3022,056
Revenue Growth
14.31%14.55%13.27%8.00%11.96%14.35%
Cost of Revenue
1,7991,6761,4881,3351,2031,035
Gross Profit
1,6731,5491,3281,1511,0991,021
Selling, General & Admin
874.15791.49730.61683.37604.7542.4
Other Operating Expenses
-77.81-35.84-31.4517.99-45.83-35.86
Operating Expenses
870.46821.89767.12756616.05561.16
Operating Income
802.39727.36560.67394.96482.66459.41
Interest Expense
-28.43-23.46-31.21-20.36-10.03-9.11
Interest & Investment Income
0.820.480.640.470.460.38
Earnings From Equity Investments
-2.73-1.36-0.64-0.33-0.02-0.12
Currency Exchange Gain (Loss)
12.1821.5311.4318.293.982.86
Other Non Operating Income (Expenses)
-2.47-2.14-4.020.982.48-0.07
EBT Excluding Unusual Items
781.76722.42536.86394.01479.54453.35
Gain (Loss) on Sale of Investments
0.160.1613.17--6.54-
Gain (Loss) on Sale of Assets
0.140.01-0.0773.3400.03
Asset Writedown
-78.81-67.55-30.88-31.7-27.95-32.79
Other Unusual Items
-44.24-31.06-26.38-48.06-28.13-13.17
Pretax Income
659.01623.99492.71387.6416.92407.42
Income Tax Expense
248.64235.76175.48123.85149.79132.48
Earnings From Continuing Operations
410.37388.23317.22263.75267.13274.95
Minority Interest in Earnings
-3.47-2.7-1.94-0.99-0.523.9
Net Income
406.9385.53315.29262.76266.62278.85
Net Income to Common
406.9385.53315.29262.76266.62278.85
Net Income Growth
17.85%22.28%19.99%-1.45%-4.39%21.13%
Shares Outstanding (Basic)
543836363636
Shares Outstanding (Diluted)
543836363636
Shares Change
148.09%5.65%----
EPS (Basic)
7.5910.148.767.307.417.75
EPS (Diluted)
7.5910.148.767.307.407.74
EPS Growth
-52.54%15.74%19.99%-1.37%-4.39%21.04%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
503.07382.42120.94-17.7286.33265.13
Free Cash Flow Per Share
9.3910.053.36-0.492.407.37
Dividend Per Share
6.6006.6005.6003.4005.0005.000
Dividend Growth
17.86%17.86%64.71%-32.00%0%376.19%
Gross Margin
48.18%48.03%47.15%46.30%47.73%49.64%
Operating Margin
23.11%22.55%19.91%15.89%20.97%22.35%
Profit Margin
11.72%11.95%11.20%10.57%11.58%13.56%
Free Cash Flow Margin
14.49%11.86%4.29%-0.71%3.75%12.90%
EBITDA
850.67767.76628.62449.6539.84514.04
EBITDA Margin
24.50%23.80%22.32%18.09%23.45%25.00%
D&A For EBITDA
48.2840.467.9654.6457.1854.63
EBIT
802.39727.36560.67394.96482.66459.41
EBIT Margin
23.11%22.55%19.91%15.89%20.97%22.35%
Effective Tax Rate
37.73%37.78%35.62%31.95%35.93%32.52%
Advertising Expenses
-68.9353.8255.2652.0945.89